Contract W81K0223P0115
Phadia Us Inc · Department Of Defense · July 23, 2025
Phadia Us Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on July 23, 2025 for $209,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Portage, MI. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 4, 2025. If all options are exercised, the contract could reach $596,000.
Contract details
- PIID
- W81K0223P0115
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Portage, MI
- First action
- July 23, 2025
- Latest action
- December 4, 2025
Description
FY26 FUNDING.
Modification timeline
-
December 4, 2025Mod P00007 · Funding Only Action$596.5K
-
July 23, 2025Mod P00006 · Exercise An OptionEXERCISE OPTION II AND ACWS NOTIFICATION OF COMPLETION.$387.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0223P0115?
Contract W81K0223P0115 is a federal contract awarded to Phadia Us Inc by Department Of Defense on July 23, 2025 for $209,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract W81K0223P0115?
Phadia Us Inc won contract W81K0223P0115 from Department Of Defense.
How much is contract W81K0223P0115 worth?
Contract W81K0223P0115 has obligated $209,000 to date, with a total potential value of $596,000 if all options are exercised.